Rezvilutamide (SHR3680) is an orally available androgen receptor inhibitor that crosses the blood-brain barrier and has antitumor activity.Rezvilutamide (SHR3680) is used in the study of metastatic desmoplasia-resistant prostate cancer.
Molecular Weight:
479.47
Purity:
0.9997
CAS Number:
[1572045-62-5]
Formula:
C22H20F3N3O4S
Target:
Androgen Receptor
T39044
* VAT and and shipping costs not included. Errors and price changes excepted